Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | A molecular-based approach to MM treatment

Jonathan Keats, PhD, Translational Genomics Research Institute, Phoenix, AZ, discusses a molecular-based approach to targeting early stages of cancer development, speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.